Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c‐Met signaling promotes IL‐6‐induced myeloma cell proliferation

31 Jan 2009

Abstract excerpt

OBJECTIVES: Hepatocyte growth factor (HGF) is a constituent of the myeloma microenvironment and is elevated in sera from myeloma patients compared to healthy individuals. Increased levels of serum HGF predict a poor prognosis. It has previously been shown by us and others HGF can act as a growth factor to myeloma cells in vitro although these effects have been moderate. We therefore wanted to investigate if HGF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver physiology and pathology
Share to Multiple Myeloma Research and Treatments
Share to Proteoglycans and glycosaminoglycans research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19187270
DOI: 10.1111/j.1600-0609.2009.01212.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

c‐Met signaling promotes IL‐6‐induced myeloma cell proliferationPMID 19187270Read ↗

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorSemantic proximity Read ↗

Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell LinesSemantic proximity Read ↗

Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells.Semantic proximity Read ↗

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.Semantic proximity Read ↗

Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266Semantic proximity Read ↗

Hepatocyte growth factor/scatter factor-induced intracellular signalling.Semantic proximity Read ↗

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.Semantic proximity Read ↗

The role of hepatocyte growth factor and its receptor <i>c‐met</i> in interactions between lymphocytes and stromal cells in secondary human lymphoid organsSemantic proximity Read ↗

Mcl‐1 and Bcl‐x<sub>L </sub> are co‐regulated by IL‐6 in human myeloma cellsSemantic proximity Read ↗

A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growthSemantic proximity Read ↗

IL-6–Induced Stimulation of c-<i>Myc</i> Translation in Multiple Myeloma Cells Is Mediated by Myc Internal Ribosome Entry Site Function and the RNA-Binding Protein, hnRNP A1Semantic proximity Read ↗

Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.